A Chinese journalist with close ties to the ruling Communist Party mocked President Trump Tuesday, charging that the commander in chief was using “witchcraft” to fight the coronavirus pandemic after the commander-in-chief said he was taking hydroxychloroquine to ward off the virus.
“President Trump is leading the US’s struggle against pandemic with witchcraft, and as a result, more than 90,000 people have died. If it were in China, the White House would have been burned down by angry people,” Hu Xijin, editor-in-chief of the Chinese Communist Party’s official publication, Global Times, wrote in a since-deleted tweet, The Daily Mail reported.
Hu — who is close with China’s leaders — made his comment after Trump announced Monday that he’s been taking the antimalarial drug hydroxychloroquine as a preventative measure despite warnings from the Food and Drug Administration that it could be dangerous or even lethal.
“You’d be surprised at how many people are taking it, especially the frontline workers before you catch it. The frontline workers — many, many are taking it. I happen to be taking it. I happen to be taking it — hydroxychloroquine,” Trump said Monday at the White House.
“A lot of good things have come out on the hydroxy. I’m taking hydroxychloroquine. I’ve been taking it. I hope to not be able to take it soon. But I think people should be allowed to,” he said.
Asked about those comments Tuesday, White House Press Secretary Kayleigh McEnany said Trump wanted to be “transparent” with Americans by disclosing that he had been taking the drug.
“The president just wanted to be transparent about his personal health decision that he made in consultation with his doctor,” McEnany told Fox & Friends.
She added that Americans should consult with their doctors before taking the medication themselves.
Some initial studies appeared to support the drug’s benefits, while others showed mixed results or even that it could be dangerous for people with certain conditions.
And the FDA has cautioned against the use of hydroxychloroquine for COVID-19 treatment outside of hospitals or clinical trials due to the potential risk of heart problems.
Source: Read Full Article